COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $339,339 | -53.0% | 14,145 | -65.3% | 0.02% | -44.7% |
Q2 2022 | $722,000 | -36.4% | 40,738 | -26.9% | 0.04% | -36.7% |
Q1 2022 | $1,135,000 | +15.0% | 55,739 | +5.5% | 0.06% | 0.0% |
Q4 2021 | $987,000 | +33.0% | 52,815 | +40.5% | 0.06% | +42.9% |
Q3 2021 | $742,000 | -30.0% | 37,589 | -16.1% | 0.04% | -26.3% |
Q2 2021 | $1,060,000 | -4.2% | 44,827 | -4.0% | 0.06% | -9.5% |
Q1 2021 | $1,107,000 | +4.2% | 46,702 | -11.9% | 0.06% | -18.2% |
Q4 2020 | $1,062,000 | -62.8% | 53,020 | -61.3% | 0.08% | -17.2% |
Q3 2020 | $2,853,000 | -7.8% | 137,049 | -22.5% | 0.09% | +16.2% |
Q2 2020 | $3,095,000 | +54.9% | 176,854 | +44.5% | 0.08% | +50.9% |
Q1 2020 | $1,998,000 | -32.0% | 122,381 | -14.3% | 0.05% | +29.3% |
Q4 2019 | $2,939,000 | +798.8% | 142,799 | +400.7% | 0.04% | +925.0% |
Q3 2019 | $327,000 | – | 28,519 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |